title: Eosinophilic inflammation in asthma.
abstract: METHODS
  The importance of eosinophils in the pathogenesis of bronchial asthma is not established. In an attempt to evaluate the role of eosinophilic inflammation in asthma, we compared 10 normal subjects with 43 patients with chronic asthma, 19 of whom had severe disease as assessed by a clinical scoring method described by Aas and by pulmonary-function tests. Eosinophils were counted in peripheral blood and bronchoalveolar-lavage fluid, and in biopsy specimens obtained from the patients and post mortem from 8 subjects without asthma, but not from the 10 normal controls. Eosinophil cationic protein was titrated by radioimmunoassay in the bronchoalveolar-lavage fluid from all subjects and studied by immunohistochemistry in the biopsy specimens.
  
  
  RESULTS
  There was a significant increase in the number of peripheral-blood eosinophils in the patients that was correlated with the clinical severity of asthma (P less than 0.001) and pulmonary function (P less than 0.03). Levels of eosinophils and eosinophil cationic protein were increased in the bronchoalveolar-lavage fluid from the patients and were also correlated with the severity of asthma (P less than 0.001 and P less than 0.002, respectively). Hematoxylin-eosin staining of bronchial-biopsy specimens showed that intraepithelial eosinophils were present only in patients with asthma. Immunohistochemical analysis of eosinophil cationic protein revealed that normal subjects had only a few nondegranulated eosinophils deep in the submucosa, whereas all the patients had degranulated eosinophils beneath the basement membrane and among epithelial cells. In some patients there was a relation between the presence of degranulated eosinophils and epithelial damage.
  
  
  CONCLUSIONS
  Eosinophilic inflammation of the airways is correlated with the severity of asthma. These cells are likely to play a part in the epithelial damage seen in this disease.
authors.affiliation: Clinique des Maladies Respiratoires, Hôpital l'Aiguelongue, Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Bousquet
authors.forename: P
authors.initials: P
authors.lastname: Chanez
authors.forename: J Y
authors.initials: JY
authors.lastname: Lacoste
authors.forename: G
authors.initials: G
authors.lastname: Barnéon
authors.forename: N
authors.initials: N
authors.lastname: Ghavanian
authors.forename: I
authors.initials: I
authors.lastname: Enander
authors.forename: P
authors.initials: P
authors.lastname: Venge
authors.forename: S
authors.initials: S
authors.lastname: Ahlstedt
authors.forename: J
authors.initials: J
authors.lastname: Simony-Lafontaine
authors.forename: P
authors.initials: P
authors.lastname: Godard
mesh_terms: D000328:Adult; D001249:Asthma / Q000473:pathology* / Q000503:physiopathology; D001798:Blood Proteins / Q000032:analysis; D001980:Bronchi / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D047091:Eosinophil Granule Proteins; D004804:Eosinophils / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation / Q000473:pathology; D007958:Leukocyte Count; D008168:Lung / Q000503:physiopathology; D008875:Middle Aged; D012260:Ribonucleases
chemical_list: D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D012260:Ribonucleases